153 related articles for article (PubMed ID: 34188983)
1. The Use of Clozapine in the Serious Mental Illness Patients Enrolled in an Assertive Community Treatment Program.
Yee MR; Espiridon E; Oladunjoye AO; Millsaps U; Harvey N; Vora AH
Cureus; 2021 May; 13(5):e15238. PubMed ID: 34188983
[TBL] [Abstract][Full Text] [Related]
2. The Use of Long-Acting Injectable Antipsychotics (LAI) in the Serious Mental Illness (SMI) Patients Enrolled in an Assertive Community Treatment (ACT) Program.
Yee MR; Espiridon E; Oladunjoye AO; Millsaps U; Vora A; Harvey N
Cureus; 2021 Apr; 13(4):e14490. PubMed ID: 34007745
[TBL] [Abstract][Full Text] [Related]
3. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
4. Psychiatric hospital utilization in patients treated with clozapine for up to 4.5 years in a state mental health care system.
Reid WH; Mason M
J Clin Psychiatry; 1998 Apr; 59(4):189-94. PubMed ID: 9590670
[TBL] [Abstract][Full Text] [Related]
5. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
6. Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT.
Morrison AP; Pyle M; Gumley A; Schwannauer M; Turkington D; MacLennan G; Norrie J; Hudson J; Bowe S; French P; Hutton P; Byrne R; Syrett S; Dudley R; McLeod HJ; Griffiths H; Barnes TR; Davies L; Shields G; Buck D; Tully S; Kingdon D
Health Technol Assess; 2019 Feb; 23(7):1-144. PubMed ID: 30806619
[TBL] [Abstract][Full Text] [Related]
7. Ethnic inequalities in clozapine use among people with treatment-resistant schizophrenia: a retrospective cohort study using data from electronic clinical records.
de Freitas DF; Patel I; Kadra-Scalzo G; Pritchard M; Shetty H; Broadbent M; Patel R; Downs J; Segev A; Khondoker M; MacCabe JH; Bhui K; Hayes RD
Soc Psychiatry Psychiatr Epidemiol; 2022 Jul; 57(7):1341-1355. PubMed ID: 35246709
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Impact of COVID-19 Vaccination on Patients Taking Clozapine.
Demler TL; O'Donnell C
Innov Clin Neurosci; 2023; 20(1-3):32-38. PubMed ID: 37122573
[TBL] [Abstract][Full Text] [Related]
9. Increasing physical activity for veterans in the Mental Health Intensive Case Management Program: A community-based intervention.
Harrold SA; Libet J; Pope C; Lauerer JA; Johnson E; Edlund BJ
Perspect Psychiatr Care; 2018 Apr; 54(2):266-273. PubMed ID: 28762507
[TBL] [Abstract][Full Text] [Related]
10. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
11. Impact of smoking cessation on psychiatric inpatients treated with clozapine or olanzapine.
Cole ML; Trigoboff E; Demler TL; Opler LA
J Psychiatr Pract; 2010 Mar; 16(2):75-81. PubMed ID: 20511731
[TBL] [Abstract][Full Text] [Related]
12. [Difficult-to-engage patients: What evolution after discharge from Assertive Community Programs?].
Vidal S; Correa L; Perroud N; Huguelet P
Encephale; 2021 Oct; 47(5):426-434. PubMed ID: 33648751
[TBL] [Abstract][Full Text] [Related]
13. Clozapine treatment in a population of adults with mental retardation.
Antonacci DJ; de Groot CM
J Clin Psychiatry; 2000 Jan; 61(1):22-5. PubMed ID: 10695641
[TBL] [Abstract][Full Text] [Related]
14. Smoking Cessation Intervention for severe Mental Ill Health Trial (SCIMITAR): a pilot randomised control trial of the clinical effectiveness and cost-effectiveness of a bespoke smoking cessation service.
Peckham E; Man MS; Mitchell N; Li J; Becque T; Knowles S; Bradshaw T; Planner C; Parrott S; Michie S; Shepherd C; Gilbody S
Health Technol Assess; 2015 Mar; 19(25):1-148, v-vi. PubMed ID: 25827850
[TBL] [Abstract][Full Text] [Related]
15. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
Rothbard AB; Lee S; Blank MB
J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
[TBL] [Abstract][Full Text] [Related]
16. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
[TBL] [Abstract][Full Text] [Related]
17. A bespoke smoking cessation service compared with treatment as usual for people with severe mental ill health: the SCIMITAR+ RCT.
Peckham E; Arundel C; Bailey D; Crosland S; Fairhurst C; Heron P; Hewitt C; Li J; Parrott S; Bradshaw T; Horspool M; Hughes E; Hughes T; Ker S; Leahy M; McCloud T; Osborn D; Reilly J; Steare T; Ballantyne E; Bidwell P; Bonner S; Brennan D; Callen T; Carey A; Colbeck C; Coton D; Donaldson E; Evans K; Herlihy H; Khan W; Nyathi L; Nyamadzawo E; Oldknow H; Phiri P; Rathod S; Rea J; Romain-Hooper CB; Smith K; Stribling A; Vickers C; Gilbody S
Health Technol Assess; 2019 Sep; 23(50):1-116. PubMed ID: 31549622
[TBL] [Abstract][Full Text] [Related]
18. People with serious mental illness are at higher risk for acute care hospitalization in Israel, 2000-2019.
Gordon ES; Yoffe R; Goldberger NF; Meron J; Haklai Z
Isr J Health Policy Res; 2022 Sep; 11(1):32. PubMed ID: 36076270
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
